BIOGEN INC. Net Income Loss

Quick Answer

BIOGEN INC. reported Net Income Loss of $1.29 billion for the year ending 2025.

  • BIOGEN INC. showed a decrease of -20.8% in Net Income Loss from 2024 to 2025.
  • This data is from BIOGEN INC.'s annual report (Form 10-K), filed with the SEC on February 6, 2026.
  • XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2014: $480.00 million | Q2 2014: $714.50 million | Q3 2014: $856.90 million | Q4 2014: $883.50 million | Q1 2015: $822.50 million | Q2 2015: $927.30 million | Q3 2015: $965.60 million | Q4 2015: $831.60 million | Q1 2016: $970.90 million | Q2 2016: $1.05 billion | Q3 2016: $1.03 billion | Q4 2016: $649.20 million | Q1 2017: $747.60 million | Q2 2017: $862.80 million | Q3 2017: $1.23 billion | Q4 2017: -$297.40 million | Q1 2018: $1.17 billion | Q2 2018: $866.60 million | Q3 2018: $1.44 billion | Q4 2018: $946.80 million | Q1 2019: $1.41 billion | Q2 2019: $1.49 billion | Q3 2019: $1.55 billion | Q4 2019: $1.44 billion | Q1 2020: $1.40 billion | Q2 2020: $1.54 billion | Q3 2020: $701.50 million | Q4 2020: $357.90 million | Q1 2021: $410.20 million | Q2 2021: $448.50 million | Q3 2021: $329.20 million | Q1 2022: $303.80 million | Q2 2022: $1.06 billion | Q3 2022: $1.13 billion | Q1 2023: $387.90 million | Q2 2023: $591.60 million | Q3 2023: -$68.10 million | Q1 2024: $393.40 million | Q2 2024: $583.60 million | Q3 2024: $388.50 million | Q1 2025: $240.50 million | Q2 2025: $634.80 million | Q3 2025: $466.50 million.
  • Over the full 18 years of available data (2008 to 2025), BIOGEN INC.'s Net Income Loss has grown by 65.1%.
  • Historical annual values: Fiscal year 2025: $1.29 billion | Fiscal year 2024: $1.63 billion | Fiscal year 2023: $1.16 billion | Fiscal year 2022: $3.05 billion | Fiscal year 2021: $1.56 billion | Fiscal year 2020: $4.00 billion | Fiscal year 2019: $5.89 billion | Fiscal year 2018: $4.43 billion | Fiscal year 2017: $2.54 billion | Fiscal year 2016: $3.70 billion | Fiscal year 2015: $3.55 billion | Fiscal year 2014: $2.93 billion | Fiscal year 2013: $1.86 billion | Fiscal year 2012: $1.38 billion | Fiscal year 2011: $1.23 billion | Fiscal year 2010: $1.01 billion | Fiscal year 2009: $970.13 million | Fiscal year 2008: $783.17 million.
  • Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: